Hepatocyte growth factor as an indicator of neonatal maturity
Authors:
- Gema Jimenez-GomezGJGema Jimenez-Gomez
- Isabel Benavente-FernandezIBIsabel Benavente-Fernandez
- Simon P. Lubian-LopezSLSimon P. Lubian-Lopez
- Manuel Matias-VegaMMManuel Matias-Vega
- Jose L. Lechuga-CampoyJLJose L. Lechuga-Campoy
- Ana Saez-BenitoASAna Saez-Benito
- Alfonso M. Lechuga-SanchoALAlfonso M. Lechuga-Sancho
- German PerdomoGerman Perdomo
- 1 January 2013
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 26 (7-8) , 709-714
Abstract
Hepatocyte growth factor (HGF) is a potent mitogen and morphogen expressed in fetal organs. It requires activation by specific serine proteases. The role of activated HGF during fetal development has not been evaluated. We hypothesized that the serum levels of activated HGF would be increased in preterm neonates. Cord blood total HGF and activated HGF levels were measured in 19 preterm (gestational age, 28.04±2.39 weeks) and 24 term (gestational age, 39.37±0.95 weeks) newborns. Anthropometric parameters and metabolic indices were evaluated. Activated HGF was higher in preterm than in term neonates (0.81±0.05 vs. 0.61±0.06 ng/mL, p<0.05), whereas total HGF levels did not differ significantly between groups. In addition, total and activated HGF further increased by ∼40% in preterm neonates 12 h after birth. Finally, activated HGF correlated inversely with gestational age (r=-0.369; p=0.015) and birth weight (r=-0.440; p=0.003). Our study demonstrates that regulation of HGF activity and circulating HGF levels differ between term and preterm neonates along fetal development.Keywords
This publication has 7 references indexed in Scilit:
- Hepatocyte Growth Factor is Elevated in Obese AdolescentsJournal of Pediatric Endocrinology and Metabolism, 2009
- Strong Association between Serum Hepatocyte Growth Factor and Metabolic SyndromeThe Journal of Clinical Endocrinology & Metabolism, 2005
- Hepatocyte growth factor gene therapy for islet transplantationExpert Opinion on Biological Therapy, 2004
- Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factorCancer and Metastasis Reviews, 2003
- Obesity is associated with increased levels of circulating hepatocyte growth factorJACC, 2003
- Hepatocyte growth factor in renal disease: cause or cure?Cellular and Molecular Life Sciences, 1999
- Extracellular proteolytic cleavage by urokinase is required for activation of hepatocyte growth factor/scatter factor.The EMBO Journal, 1992